TrialJournal of immunology research2016

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.

Michal Lotem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.